<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR24">
 <label>24.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Chan</surname>
    <given-names>JF-W</given-names>
   </name>
   <name>
    <surname>Zhu</surname>
    <given-names>Z</given-names>
   </name>
   <name>
    <surname>Chu</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Yuan</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Chik</surname>
    <given-names>KK-H</given-names>
   </name>
   <name>
    <surname>Chan</surname>
    <given-names>CC-S</given-names>
   </name>
   <name>
    <surname>Poon</surname>
    <given-names>VK-M</given-names>
   </name>
   <name>
    <surname>Yip</surname>
    <given-names>CC-Y</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>X</given-names>
   </name>
   <name>
    <surname>Tsang</surname>
    <given-names>JO-L</given-names>
   </name>
   <name>
    <surname>Zou</surname>
    <given-names>Z</given-names>
   </name>
   <name>
    <surname>Tee</surname>
    <given-names>K-M</given-names>
   </name>
   <name>
    <surname>Shuai</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Lu</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Yuen</surname>
    <given-names>K-Y</given-names>
   </name>
  </person-group>
  <article-title>The celecoxib derivative kinase inhibitor AR-12 (OSU-03012) inhibits Zika virus via down-regulation of the PI3K/Akt pathway and protects Zika virus-infected A129 mice: a host-targeting treatment strategy</article-title>
  <source>Antivir Res</source>
  <year>2018</year>
  <volume>160</volume>
  <fpage>38</fpage>
  <lpage>47</lpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2018.10.007</pub-id>
  <?supplied-pmid 30326204?>
  <pub-id pub-id-type="pmid">30326204</pub-id>
 </element-citation>
</ref>
